Hsa_circ_0069094 accelerates cell malignancy and glycolysis through regulating the miR-591/HK2 axis in breast cancer

被引:18
|
作者
Xing, Zeyu [1 ]
Wang, Xin [1 ]
Liu, Jiaqi [1 ]
Zhang, Menglu [1 ]
Feng, Kexin [1 ]
Wang, Xiang [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Breast Canc,Natl Canc Ctr, 151 Panjiayuan Nanli, Beijing 100021, Peoples R China
关键词
BC; circ_0069094; miR-591; HK2; Glycolysis; ENERGY-METABOLISM; RESISTANCE; S100P;
D O I
10.1016/j.cellsig.2020.109878
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Circular RNAs (circRNAs) are implicated in the initiation and advancement of diverse tumors. CircRNA hsa_circ_0069094 (circ_0069094) has been reported to be upregulated in BC, but the biological role of circ_0069094 in BC is indistinct. Hence, we aimed to survey the biological role of circ_0069094 in BC. In the present study, we verified that circ_0069094 was upregulated in BC tissues and cells. BC patients with high circ_0069094 expression had a poor prognosis. Functional analysis revealed that circ_0069094 silencing induced apoptosis, curbed proliferation, and reduced glycolysis in BC cells in vitro, but circ_0069094 overexpression had an opposing influence. Also, circ_0069094 knockdown reduced BC growth in vivo. Mechanically, circ_0069094 was validated as a decoy for miR-591, which targeted HK2. Importantly, circ_0069094 sponged miR-591 to regulate HK2 expression. Both miR-591 silencing and HK2 overexpression counteracted circ_0069094 inhibition-mediated influence on cell proliferation, apoptosis, and glycolysis in BC cells. In conclusion, these results indicated that circ_0069094 facilitated cell malignancy and glycolysis by upregulating HK2 through adsorbing miR591, suggesting that circ_0069094 might be a prognostic biomarker and therapeutic target for BC.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Hsa_circ_0069094 knockdown inhibits cell proliferation, migration, invasion and glycolysis, while induces cell apoptosis by miR-661/HMGA1 axis in breast cancer
    Sui, Chao
    Qu, Wei
    Lian, Yanfen
    Feng, Chuanbo
    Zhan, Yi
    ANTI-CANCER DRUGS, 2021, 32 (08) : 829 - 841
  • [2] Hsa_circ_0087862 contributes to the progression of colorectal cancer through regulating miR-512-3p/HK2 axis
    Chen, Yu
    Chen, Lu
    Wu, Jieyun
    Su, Dazhi
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 257
  • [3] Hsa_circ_0001806 promotes glycolysis and cell progression in hepatocellular carcinoma through miR-125b/HK2
    Chen, Xueyi
    She, Pengyun
    Wang, Caihua
    Shi, Lina
    Zhang, Tieying
    Wang, Yanfei
    Li, Haixia
    Qian, Lu
    Li, Man
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (12)
  • [4] Hsa_circ_0045932 regulates the progression of colorectal cancer by regulating HK2 through sponging miR-873-5p
    Hong, Feng
    Deng, Zhihua
    Tie, Ruxiu
    Yang, Senlin
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (09)
  • [5] Circ_0002762 accelerates glycolysis metabolism to promote cervical cancer progression via the miR-526b-5p/HK2 axis
    Zhao, Nian
    Hu, Ling
    Chen, Hui
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2023, 87 (06) : 352 - 363
  • [6] Downregulation of hsa_circ_0006620 inhibits the malignant progression of prostate cancer by regulation of the miR-502-3p/HK2 axis mediated by aerobic glycolysis
    Jin, Mingming
    Wang, Menghan
    Luo, Yulin
    Yuan, Taile
    Li, Xue
    Huang, Gang
    Huang, Qingqing
    Sun, Hong
    CLINICAL & EXPERIMENTAL METASTASIS, 2024, 41 (06) : 947 - 958
  • [7] Circ_0091581 Promotes the Progression of Hepatocellular Carcinoma Through Targeting miR-591/FOSL2 Axis
    Ji, Chenggang
    Hong, Xiaocheng
    Lan, Bo
    Lin, Ye
    He, Yingxin
    Chen, Jiayang
    Liu, Xi
    Ye, Weijie
    Mo, Zhikang
    She, Zhanpeng
    Lin, Shuwen
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (09) : 3074 - 3085
  • [8] Circ_0091581 Promotes the Progression of Hepatocellular Carcinoma Through Targeting miR-591/FOSL2 Axis
    Chenggang Ji
    Xiaocheng Hong
    Bo Lan
    Ye Lin
    Yingxin He
    Jiayang Chen
    Xi Liu
    Weijie Ye
    Zhikang Mo
    Zhanpeng She
    Shuwen Lin
    Digestive Diseases and Sciences, 2021, 66 : 3074 - 3085
  • [9] Downregulation of Circ-PITHD1 Suppressed Colorectal Cancer via Glycolysis Inhibition through miR-590-5p/HK2 Axis
    Yang, Shiguang
    Zhao, Kui
    Yang, Xiaodong
    Xing, Chungen
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [10] Hsa_Circ_002144 Promotes Glycolysis and Immune Escape of Breast Cancer Through miR-326/PKM Axis
    Yang, Yong
    Xie, Tianhao
    Gao, Peng
    Han, Weijun
    Liu, Yuhong
    Wang, Yanmei
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2024, 39 (10) : 755 - 769